Oriental Aromat. Q4 FY23 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 5
Margin
Category 4
Fundraise
Yes
Order
N/A
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 5- The company anticipates a challenging next 2-3 quarters with subdued demand and pricing pressures, especially in camphor and aroma chemicals divisions.
- Strong growth is expected in the fragrance division driven by new wins and participation in more projects, though overall industry growth is uncertain.
- Capacity expansions (Brownfield and Greenfield) are ongoing, expected to complete by FY24, potentially enabling higher volumes in 2-3 years.
- Management aims for profitable growth focusing on efficient raw material procurement, cost reduction, and process improvements rather than just volume increase.
- Stabilization of demand and pricing is expected after 2-3 quarters, potentially leading to stable EBITDA and higher sales clarity thereafter.
- Due to prevailing uncertainties in raw material prices, demand, and competition, precise revenue or volume guidance is deferred until clearer market conditions emerge.
See what Oriental Aromat. management said on margin guidance — free account, 30 seconds.
Fundraise plans
Yes- The company is undertaking a phased investment approach, currently piloting the CSTP before proceeding with further investments.
- Peak debt levels by the end of the current year are expected to be around ₹370-450 crores.
- For ongoing and planned CAPEX (Baroda, Mahad, Bareilly), the company plans to fund approximately 70-75% of the total project cost through debt.
- Mahad project’s total planned investment is about ₹100 crores, with ₹25-32 crores already invested.
- No explicit mention of raising equity funds in the transcript.
- Focus remains on managing internal operations and strategic investment phases with controlled debt funding aligned to project progress.
See what Oriental Aromat. management said on order book — free account, 30 seconds.
Capex plans
Yes- The company has ongoing and planned capex across multiple locations: Baroda, Bareilly, and Mahad.
- Baroda capex balance is around ₹100 crore; Mahad greenfield project expected cost is ₹92-100 crore; Bareilly capex remaining is small (₹6-7 crore).
- Total capex planned for FY24 is about ₹200-205 crore.
- Debt funding expected at 70-75% of total project cost, with peak debt around ₹370-380 crore by year-end.
- Mahad project is phased, with ₹25-32 crore already invested; total planned investment about ₹100 crore.
- The new plant validation and market capture are expected over 6-9 months, aiming to capture 40-50% market share within 2.5 years.
- The company continues to invest strategically while focusing on derisking and China Plus One strategy despite market challenges.
- Expansion including the CSTP project expected to complete mostly by FY24.
Track Oriental Aromat. — get its next earnings analysis in your feed
Margin guidance
Category 4- The company expects a challenging next 2-3 quarters due to subdued demand, pricing pressure, and external factors, particularly in camphor and aroma chemicals.
- Management is focusing on internal process improvements and productivity enhancements to remain lean and profitable when demand stabilizes.
- They are cautious about providing specific guidance for turnover or earnings in the near term due to volatility in raw material prices and market conditions.
- Capex of around ₹200-205 crore (Baroda, Bareilly, Mahad) is planned for FY24, which will support future capacity and growth once market conditions improve.
- Emphasis remains on profitable growth rather than volume growth alone, aiming to optimize margins via raw material procurement and operational efficiencies.
- Recovery and upward trajectory in earnings, ROE, and ROCE are expected to become clearer after 6-8 quarters when the market stabilizes and new capacities come online.
Order book
- The company indicated that for H1 2023, customer RFQs (Request for Quotations) allocations have been honored to about 60-70%, with the remaining either postponed or canceled, reflecting softness in demand.
- Inventory buildup is relatively high due to postponed procurements by global customers and slowdown in Europe and America.
- There is a challenging environment with subdued demand and oversupply, especially in the camphor market.
- Due to these factors, a clearer picture on order book stabilizing is expected only after two to three quarters.
- The management prefers not to provide firm guidance at this moment due to market uncertainties.
- They are seeing increased participation in new fragrance and flavor projects which is helping the fragrance division grow despite overall market challenges.
How does Oriental Aromat. rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does Oriental Aromat. rank in Chemicals & Petrochemicals?
Compare Oriental Aromat. against every Chemicals & Petrochemicals company (Q4 FY23) on revenue, margins and earnings-call signals.
Continue your research
What Oriental Aromat.'s management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Sudarshan Chemical Industries Ltd (Q1 FY27)
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
- Indo Borax & Ch. (Q1 FY27)
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
- SRF (Q1 FY27)
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…
- Deepak Fertilis. (Q1 FY27)
Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions. Key concall takeaways from…